636 Addition of GITR agonist to a dark matter cancer vaccine and anti-PD-1 increases regulatory T cell numbers without appearing to impact therapeutic efficacyRom S. Leidner, Bernard A. Fox, Shawn M. Jensen et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0